iLABMED presents the latest developments in the clinical laboratory sciences. We cover key topics in all aspects of laboratory medicine and related multidisciplinary research.

Focusing on computer and data science enabled intelligent medicine, we unite researchers and clinicians from diverse medical subspecialities, including artificial intelligence, bioinformatics, proteomics, materials and more, to enable collaboration and further advance the field.

Journal Metrics

  • 68%Acceptance rate
  • 21 days Submission to first decision
view all metrics
Skip slideshow

Articles

REVIEW
Open access

Current Progress in Targeting Human Cytomegalovirus Infection

  •  3 July 2025

Graphical Abstract

Current Progress in Targeting Human Cytomegalovirus Infection Issue ,

This review highlights recent advances in the mechanisms by which human cytomegalovirus (HCMV) maintains its genome in infected cells, as well as the cellular factors and viral antigens that modulate viral reactivation, which reveal potential targets for addressing HCMV infection. Additionally, the review discusses the development of therapeutics and vaccines against HCMV.

REVIEW
Open access

Recent Advances in DNA‐Based Strategies for the Capture, Detection, and Release of Circulating Tumor Cells

  •  2 July 2025

Graphical Abstract

Recent Advances in DNA-Based Strategies for the Capture, Detection, and Release of Circulating Tumor Cells Issue ,

Circulating tumor cell (CTC) analysis has become a powerful tool for the early diagnosis of cancer, monitoring disease progression, and evaluating treatment efficacy. This article reviews the latest progress in CTC detection, capture, and release methods based on DNA materials and provides insights into current development trends and future research directions. We give a comprehensive overview of various strategies and discuss their design principles, characteristics, advantages, and limitations and the challenges faced by the CTC research field.

ORIGINAL ARTICLE
Open access

Analysis of the Clinical Value of Monocyte Human Leukocyte Antigen‐DR, Procalcitonin, and C‐Reactive Protein in Sepsis

  •  1 July 2025

Graphical Abstract

Analysis of the Clinical Value of Monocyte Human Leukocyte Antigen-DR, Procalcitonin, and C-Reactive Protein in Sepsis Issue ,

This study compared the clinical value of monocytic human leukocyte antigen-DR (mHLA-DR), procalcitonin (PCT), and C-reactive protein (CRP) in diagnosing and predicting sepsis outcomes, providing better guidance for clinical management. The diagnostic efficacy of PCT and CRP for sepsis was superior to that of mHLA-DR, but mHLA-DR demonstrated a significantly better predictive efficacy than PCT in evaluating sepsis prognosis, while there was no significant difference in CRP levels between the survival and non-survival groups.

REVIEW
Open access

Extrachromosomal Circular DNA: Emerging Insights Into Cardiovascular Disease Mechanisms and Biomarker Potential

  •  29 June 2025

Graphical Abstract

Extrachromosomal Circular DNA: Emerging Insights Into Cardiovascular Disease Mechanisms and Biomarker Potential Issue ,

Extrachromosomal circular DNA (eccDNA) has quite recently turned out to be a cardinal component in cardiovascular diseases (CVD), governing the gene expression and mechanisms of disease causation. Studies indicated an upregulation of eccDNA in pulmonary arterial hypertension (PAH), which makes it strikingly potential as a sensitive and specific biomarker. High-throughput sequencing advances enabled the detection of massive amounts of eccDNA from plasma, opening a new horizon in non-invasive diagnosis. Future studies shall elucidate the understanding of functional roles in CVD and provide novel therapies coupled with better clinical outcomes.

REVIEW
Open access

Electrical Impedance Tomography in Medical Applications: Brain and Lung

  •  28 June 2025

Graphical Abstract

Electrical Impedance Tomography in Medical Applications: Brain and Lung Issue ,

The clinical focus of EIT technology lies in lung function monitoring and neurological diseases, while also exploring new scenarios such as abdominal hemorrhage detection. Technological breakthroughs include the development of wearable devices and the optimization of hardware architecture. However, there are still challenges, such as limited spatial resolution, susceptibility to interference, and motion artifacts. In the future, with the advancement of intelligence and portability, EIT has great potential in personalized medicine and improving the level of intensive care.

More articles

The following is a list of the most cited articles based on citations published in the last three years, according to CrossRef.

Open access

Bottlenecks and recent advancements in detecting Mycobacterium tuberculosis in patients with HIV

  •  44-57
  •  10 May 2023

Graphical Abstract

Bottlenecks and recent advancements in detecting Mycobacterium tuberculosis in patients with HIV Issue 1, 2023

Tuberculosis (TB) is difficult to diagnose, particulally in HIV-positive individuals, leading to a delayed disease treatment and poor prognosis. Herein, we summarize the strengths and limitations of current TB diagnostic methods, and shed light on the obstacles of TB diagnosis in people living with HIV. In addition, we discuss newly-emerging technologies and advocate for combining multiple diagnostic tools to develop alternative strategies for TB diagnosis, especially in cases of HIV/TB co-infection.

Open access

Single cell metabolic phenome and genome via the ramanome technology platform: Precision medicine of infectious diseases at the ultimate precision?

  •  5-14
  •  9 May 2023

Graphical Abstract

Single cell metabolic phenome and genome via the ramanome technology platform: Precision medicine of infectious diseases at the ultimate precision? Issue 1, 2023

At precisely one microbial cell resolution, the SCIVVS strategy enables total live cell counting, rapid species identification, species-resolved in situ vitality and antimicrobial susceptibility test, and source tracking directly from an infected clinical specimen. The integrated workflow is culture-free, fast, cost-effective and can be automated, making it a promising new tool in combating bacterial or fungal infections.

Open access

Clinical utility of six serum tumor markers for the diagnosis of lung cancer

  •  132-141
  •  12 September 2023

Graphical Abstract

Clinical utility of six serum tumor markers for the diagnosis of lung cancer Issue 2, 2023

This article investigated the clinical utility of the six serum tumor markers in differentiating between lung cancer and benign lung diseases through the comparative analysis of patient samples, and proved that combining the detection of ProGRP, NSE, CYFRA21-1, CEA, and SCCA significantly improves sensitivity when diagnosing lung cancer.

Open access

Diagnostic approaches for monkeypox virus

  •  6-13
  •  7 March 2024

Graphical Abstract

Diagnostic approaches for monkeypox virus Issue 1, 2024

This review highlights the technical details, application scenarios, and the advantages and disadvantages of MPXV-specific diagnostic methods. The main diagnostic techniques include (1) monkeypox virus isolation and culture (2) immunoassays (3) molecular methods (4) electron microscopy. In addition, the types of specimens for MPXV detection and their uses are introduced.

Open access

Research progress of CRISPR/Cas systems in nucleic acid detection of infectious diseases

  •  58-74
  •  13 May 2023

Graphical Abstract

Research progress of CRISPR/Cas systems in nucleic acid detection of infectious diseases Issue 1, 2023

In this review, we presented the development and mechanism of the CRISPR/Cas system together with representative CRISPR/Cas applications in nucleic acid detection. Additionally, the review summarizes future perspectives and trends of the CRISPR/Cas system in nucleic acid detection.

More articles

Latest news

Recent issues